{
  "nctId": "NCT06336239",
  "briefTitle": "PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study",
  "officialTitle": "PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a National Cross-sectional Study",
  "protocolDocument": {
    "nctId": "NCT06336239",
    "filename": "Prot_000.pdf",
    "label": "Study Protocol",
    "date": "2023-10-26",
    "uploadDate": "2024-02-29T04:49",
    "size": 711941,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT06336239/document/Prot_000.pdf",
    "hasProtocol": true,
    "hasSap": false,
    "hasIcf": false
  },
  "phase": [],
  "studyType": "OBSERVATIONAL",
  "enrollmentInfo": {
    "enrollmentCount": 3000,
    "enrollmentType": "ESTIMATED"
  },
  "timeline": {
    "startDate": "2023-12-21",
    "completionDate": "2024-12-30",
    "primaryCompletionDate": "2024-07-09",
    "firstSubmitDate": "2023-12-27",
    "firstPostDate": "2024-03-28"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Age ≥18 years old;\n* Diagnosed T2DM combined with ≥1 CVD (hypertension, coronary heart disease, atrial fibrillation, heart failure);\n* During the data collection period, they went to the outpatient clinic of the cardiology department of the research center, or received treatment in the cardiology department;\n* Ability to self-sign informed consent (electronic /paper).\n\nExclusion Criteria:\n\n* Pregnant or lactating women;\n* Dialysis patients;\n* Other diseases that lead to elevated albuminuria, such as severe infection, confirmed primary glomerular disease, etc.;\n\n  . Malignant tumors being treated (surgery, chemotherapy, radiotherapy or targeted therapy);\n* Cachexia (CSS score ≥ 5 points);\n* Severe liver disease (Child- Pugh grade C) ;\n* Participated in an interventional clinical trial in the past three months.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "The prevalence of albuminuria",
        "description": "To assess the prevalence of albuminuria in patients who are combined with type 2 diabetes mellitus and different cardiovascular diseases in inpatient and outpatient cardiology departments of secondary and tertiary hospitals in China.",
        "timeFrame": "On the day of patients enrollment."
      }
    ],
    "secondary": [
      {
        "measure": "Lthe prevalence of microalbuminuria and macroalbuminuria evels of microalbuminuria and macroalbuminuria",
        "description": "To evaluate the levels of microalbuminuria and macroalbuminuria of patients with type 2 diabetes mellitus (T2DM) in inpatients and outpatients cardiology departments;",
        "timeFrame": "On the day of patients enrollment."
      },
      {
        "measure": "The prevalence of microalbuminuria and macroalbuminuria",
        "description": "To evaluate the prevalence of microalbuminuria and macroalbuminuria in patients with T2DM complicated with different cardiovascular diseases",
        "timeFrame": "On the day of patients enrollment."
      },
      {
        "measure": "To evaluate the related influence factors of albuminuria and the treatment patterns of CKD patients and non-CKD patients in cardiology departments;",
        "description": "After outpatient patients receive feedback on their renal function tests, assess whether physicians prescribe new relevant medical orders by recording them. Evaluate the treatment patterns for CKD and non-CKD patients in the cardiology department.",
        "timeFrame": "On the day of patients enrollment."
      },
      {
        "measure": "Evaluate the management of patients with type 2 diabetes mellitus and cardiovascular disease across different levels of cardiology departments in hospitals.",
        "description": "Collect clinical assessment data from patients (including test results and the frequency of these tests over the past year), and assess the management of patient-related risk factors and complications by physicians in hospitals of different levels based on the frequency of testing.",
        "timeFrame": "On the day of patients enrollment."
      }
    ],
    "other": [
      {
        "measure": "Exploratory Objective",
        "description": "To evaluate the prevalence of retinopathy in T2DM patients with different cardiovascular diseases attending inpatient and outpatient cardiology departments in secondary and tertiary hospitals in China.",
        "timeFrame": "On the day of patients enrollment."
      }
    ]
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 4,
      "otherCount": 1,
      "totalCount": 6
    },
    "studyDesign": {
      "phases": [],
      "isRandomized": false,
      "isMasked": true
    },
    "overallComplexityScore": 51,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:29:10.114Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}